Skip to main content
Top
Gepubliceerd in:

Open Access 12-05-2023

The Personalized Priority and Progress Questionnaire (PPPQ): A personalized instrument for quality of life and self-management for use in clinical trials and practice

Auteurs: Judith Tommel, Cinderella K. Cardol, Andrea W. M. Evers, Rianne Stuivenberg, Sandra van Dijk, Henriët van Middendorp

Gepubliceerd in: Quality of Life Research | Uitgave 10/2023

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
insite
ZOEKEN

Abstract

Purpose

The aim of this study was to develop and validate a brief personalized instrument that (1) defines patients’ priorities for improvement, (2) measures progress in prioritized quality of life (QoL) and self-management outcomes, and (3) is applicable in both clinical practice and clinical trials.

Methods

The instrument was developed based on the literature on personalized assessment and patient priorities, feedback by clinicians, and six cognitive interviews with patients with chronic kidney disease. The resulting questionnaire, the Personalized Priority and Progress Questionnaire (PPPQ), contains a baseline and follow-op measurement. The baseline measurement assesses functioning on QoL (8 items) and self-management (5 items). The final item evaluates patients’ priorities for improvement. The follow-up measurement assesses progress in QoL and self-management. A personalized progress score can be calculated indicating the amount of progress on the QoL or self-management domain that is prioritized by the individual patient. Psychometric properties of the PPPQ were evaluated among patients with chronic kidney disease (n = 121) and patients with kidney failure treated with dialysis (n = 22).

Results

The PPPQ showed to be a feasible instrument that is easy and quick to complete. Regarding the construct validity, small to large correlations were found between the items and existing validated questionnaires measuring related constructs.

Conclusion

The PPPQ proved to be a feasible and valid instrument. The PPPQ can be adapted to match diverse populations and could be a useful tool both in clinical practice (e.g., to identify priorities and tailor treatment) and clinical trials (e.g., to evaluate the effectiveness of personalized interventions).
Opmerkingen

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s11136-023-03429-7.
Judith Tommel and Cinderella K. Cardol shared first authorship.

Trial registration number and date of registration

E-GOAL study: NL7338, registered on 2018-10-11.
E-HELD study: NL7160, registered on 2018-07-16.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Plain English Summary

1.
What is the key problem?
Treating every patient with the same treatment would mean that every patient needs the same things. However, patients are not the same. Patients differ in health, needs, preferences, and personal situations. Therefore, it is better to include these personal differences and to make sure that the treatment is the right fit. A tool that aids patients in making clear what they find important about their health and life, can help to personalize healthcare.
 
2.
What is the main point of this study?
In this study, we developed a tool that supports patients in defining their priorities for improvement and measures changes in functioning. The tool consists of a personalized questionnaire that includes questions on quality of life (e.g., fatigue, pain, mood, social environment, daily activities) and self-management (e.g., diet, physical activity, smoking). In the final question, patients select the topics they find most important to improve on.
 
3.
What do the results mean?
The questionnaire showed to be a good, practical tool. In healthcare settings, patients could complete the questionnaire before every doctor’s appointment. In this way, doctors could keep track on patients’ functioning and use the results to discuss what patients need and what kind of treatment would fit. In research settings, researchers could use the results of the questionnaire to calculate how much patients’ functioning changed on the topics patients find most important. This is useful when evaluating whether a personalized treatment works.
 

Introduction

Patients vary in functioning, preferences, goals, and values [1, 2]. Besides patients’ biological and clinical functioning, these individual differences and priorities should be incorporated in interventions [35]. Patients with chronic kidney disease (CKD) have expressed a need for holistic care that includes all aspects of a person’s health and wellbeing, including quality of life (QoL) and self-management behaviors (e.g., physical activity, dietary changes, medication use, non-smoking) [2, 6]. Moving away from a ‘mechanistic’ focus on laboratory results and focusing on patients’ actual wellbeing instead, is key for patient-centered care (PCC) [6]. PCC is defined as providing care that is respectful of and responsive to patient preferences, needs, and values and ensuring that patient values guide all clinical decisions [7]. Positive associations of PCC with enhanced QoL, wellbeing, patient satisfaction, perceived quality of care, and self-management [810], as well as improved clinical outcomes have been found, for example reductions in pain, blood pressure, complications, and hospitalization [9]. Thus, instead of evaluating one-size-fits-all interventions, the focus should be on identifying and offering the best intervention for every individual patient [11]. This calls for personalized (1) interventions and (2) outcome variables to do justice to each patient’s unique treatment trajectory [3, 4, 11].
As personalized interventions imply individual differences in treatment, standard generic outcome measures to evaluate their effectiveness will not suffice. Multiple questionnaires would be necessary to evaluate different treatment goals, which significantly harms the power of these studies since only the data of subgroups that worked on similar treatment goals can be used [4]. Moreover, generic measures invalidate the personalized character of the intervention by clouding patients’ results with unimportant or not focused-on health domains [3, 4, 11, 12]. Using personalized assessments enables to evaluate whether inventions are not only clinically, but also personally relevant to patients (i.e., personal utility) [13]. This allows general conclusions on treatment effectiveness, while considering each unique treatment trajectory. This feature makes personalized outcome measures highly valuable in research settings.
Personalized assessment can also be of great clinical value, as it helps to clarify patients’ needs and priorities. It provides a valuable asset in shared decision-making [12], in which patients have an active role in selecting treatment and care plans that match their preferences. Personalized assessments could also help to define personally-relevant treatment goals, which form the basis of personalized treatment [12]. Subsequently, personalized outcomes can monitor patient functioning over time [12]. Although incorporating patient priorities in decision-making and interventions is highly valued [7], they are not routinely assessed or recorded in medical records [14]. A personalized tool assessing priorities would make patient priorities explicitly visible in clinical practice.
However, adequate tools for use in clinical practice or trials are sparse. Several tools measure priorities or preferences, but all lack an effect assessment on health outcomes that are prioritized by patients themselves [14]. The McMaster Toronto Arthritis Patient Preference Disability Questionnaire (MACTAR) [15] assesses change in functioning areas that matter to patients, but limits feasibility by requiring trained interviewers and complex scoring [16]. Similarly, scales that focus on goal setting such as Goal Attainment Scaling (GAS) [17], the Patient Goal Priority Questionnaire (PGPQ) [18], and Self-Identified Goal Assessment (SIGA) [19] can help patients prioritize their needs for improvement, but are also time-consuming and require trained interviewers or therapists to help patients setting realistic goals [20].
This study aims to develop and validate a brief personalized instrument that is applicable to patients with diverse somatic conditions and that (1) defines patients’ priorities for improvement, (2) measures changes in functioning on patient-prioritized QoL and self-management outcomes, and (3) is applicable in both clinical practice and trials. This study evaluates the psychometric properties of the instrument in two different chronic kidney disease (CKD) samples. If feasible and valid, this brief, personalized tool can be used to easily identify, prioritize, and monitor individual problems and progress.

Methods

Study population

Questionnaire development

Using purposeful sampling, 4 patients with CKD and 2 patients with kidney failure treated with dialysis were recruited from Leiden University Medical Center to participate in the cognitive interviews.

Questionnaire evaluation

Datasets of two multicenter randomized controlled trials (RCT) were used, evaluating the effectiveness of a personalized e-health intervention in patients with CKD (E-GOAL study) [21] or kidney failure treated with dialysis (E-HELD study) [22].
Patient recruitment for the E-GOAL study took place from April 2018 through March 2020 within Dutch academic (Leiden University Medical Center, Leiden; Radboud university medical center, Nijmegen; University Medical Center Groningen, Groningen) and non-academic (Haaglanden Medical Center, The Hague) hospitals. Adult patients with CKD with an eGFR of 20–89 ml/min/1.73 m2 under treatment by an internist-nephrologist were invited to participate when their screening questionnaire indicated at least mild depressive or anxiety symptoms and that they failed to meet at least one of the nephrology self-management guidelines [23].
Patient recruitment for the E-HELD study took place from February 2019 through October 2021 within Dutch academic (Radboud university medical center, Nijmegen; Leiden University Medical Center, Leiden) and non-academic (VieCuri Medical Centre, Venlo; Bernhoven Hospital, Uden) hospitals and dialysis centers (Ravenstein Dialysis Centre, Ravenstein; Dialysis Center Groningen, Groningen). Adult patients with an eGFR < 15 ml/min/1.73 m2 treated with hemodialysis or peritoneal dialysis for at least three months were invited to participate when they presented low QoL or symptoms of fatigue, itch, depression, or anxiety on screening questionnaires.
Exclusion criteria for both studies were: age < 18 years; > 10% past-year renal-function loss, life expectancy < 12 months or serious psychiatric conditions, recent major stressful life events unrelated to kidney disease, study-interfering cognitive problems, psychological treatment, kidney transplant received or scheduled < 1 year ago or ahead, not fluent in Dutch language, pregnancy, and no access to a computer or internet. Additionally, the E-GOAL study excluded patients with anticipated need for dialysis work-up within the study time frame or a systolic blood pressure < 95 mmHg not responding to withdrawal or antihypertensives.
Ethical approval was obtained from the Medical Ethical Committee Leiden-Den Haag-Delft (E-GOAL: P17.172; E-HELD: P18.013).

Item generation

Questionnaire topics were based on research team expertise and literature on frequently reported symptoms and patient priorities in the CKD and dialysis population [2, 2427]. The questionnaire structure was based on existing personalized and goal-setting measurements [1519]. Resulting items were judged on comprehensibility and relevance by medical psychologists and nephrologists and revised accordingly.

Cognitive interviews

Six cognitive interviews were conducted with patients to evaluate item feasibility, comprehensibility and readability. Additionally, patients were asked to judge the relevance of the QoL and self-management topics addressed by the items and were invited to add or remove items. The interviewers, JT and CKC, used the think-aloud approach and verbal-probing techniques to gain insight in patient response processes [28]. In this approach, the interviewees vocalize their thoughts while answering items. Verbal-probing techniques included paraphrasing and comprehension/interpretation, recall, specific, and general probes [28]. Based on the interviews, minor textual revisions were made to the questionnaire.

Personalized priority and progress questionnaire (PPPQ)

The resulting questionnaire, called Personalized Priority and Progress Questionnaire (PPPQ), consists of baseline and progress measurements:
Baseline measurement: assesses personal priorities for improvement in QoL areas and self-management behaviors.
  • QoL: Whether patients experience limitations in QoL areas in the past 2 weeks is assessed by 8 items (fatigue, pain, itch, anxiety, depression, social environment, daily activities, and dependency), of which items can be omitted if not relevant in a particular population. Items are scored on a 5-point Likert scale (1 = not at all, 5 = extremely). An example item is “To what extent have you experienced limitations in the area of fatigue or sleep problems?”.
  • Self-management: 5 items assess medication adherence, healthy diet, physical activity, weight maintenance, and non-smoking, using 5-point Likert scales (1 = not at all, 5 = extremely well). An example item is “To what extent have you managed to always take your medication as prescribed?”.
  • Priorities: Patients make two top-2’s of the areas of QoL and self-management they prioritize for improvement and would actively commit to over the coming period.
Progress measurement: assesses progress in QoL or self-management behavior compared to baseline measurement.
  • QoL and self-management: Patients indicate whether their experienced QoL limitations and self-management behaviors changed since the baseline measurement. The items are answered using a 7-point Likert scale (− 3 = many more, 0 = remained the same, + 3 = much fewer), following the base “Compared to the last time I completed this questionnaire, …”. Higher scores indicate improved QoL or self-management behavior. Example items are: “I now experience more/similar/fewer limitations in the area of fatigue or sleep problems” (QoL) and “I have managed less well/equally well/better to always take my medication as prescribed” (self-management).
  • Priorities: Patients indicate whether they tried to improve in any QoL or self-management areas since the baseline measurement. Patients select a maximum of 2 QoL areas and 2 self-management behaviors or the options ‘other’ or ‘not applicable’ (when not worked on anything).
Progress score. The progress score indicates the amount of progress (i.e., change) on the QoL or self-management domain(s) prioritized by the patient. This score consists of the isolated scores on the progress items that were selected as priorities at baseline; if more than one was selected, an average progress score is calculated. Ultimately, this will result in one single score that includes all personally meaningful changes.
The original Dutch PPPQ was translated in English using the forward–backward method [29]. The English (PPPQ-EN) and Dutch (PPPQ-NL) versions are enclosed in Supplementary Files 1 and 2.

Measures

Patient characteristics

Socio-demographic and clinical characteristics (age, sex, education level, marital status, and comorbidity) were collected using self-administered questionnaires.
An overview of the validated measures that were administered to evaluate the construct validity of the PPPQ can be found in Table 1. Higher scores indicate worse QoL, except for the energy, pain, social functioning, and daily activities measures. Regarding self-management behavior, higher scores indicate better self-management, except for smoking behavior and BMI.
Table 1
Measures administered to evaluate the construct validity of the Personalized Priority and Progress Questionnaire (PPPQ)
Construct
Measure
Quality of life areas
 
 Fatigue
Shortened Fatigue Questionnaire (SFQ) [48]
 Sleeping problems
Sleep Problem Index II, Medical Outcomes Study (MOS) Sleep Scale [49]
 Energy
Subscale Energya, RAND Short Form-36 Health Status Inventory (RAND SF-36) [50]
 Pain
Subscale Paina, RAND Short Form-36 Health Status Inventory (RAND SF-36)) [50]
 Itch
Impact of Chronic Skin Disease on Daily Life (ISDL) [51]
 Anxiety
Generalized Anxiety Disorder 7-item Scale (GAD-7) [52]
 Worrying
Penn State Worry Questionnaire (PSWQ) [53]
 Depression
Patient Health Questionnaire depression scale (PHQ-9) [54]
 Social functioning
Subscale Social functioninga, RAND Short Form-36 Health Status Inventory (RAND SF-36)) [50]
 Perceived emotional support
Subscale Perceived support, Inventory for Social Reliance (ISR) [55]
 Actual emotional support
Subscale Actual support, Inventory for Social Reliance (ISR) [55]
 Mutual visiting
Mutual visiting, Inventory for Social Reliance (ISR) [55]
 Daily activities
Subscale role limitations due to physical problemsa, RAND Short Form-36 Health Status Inventory (RAND SF-36)) [50]
Self-management behaviors
 
 Self-management
Partners in Health Scale (PiH) [56]
 Medication adherence
Simplified Medication Adherence Questionnaire (SMAQ) [57]
 Dietary adherence
2 self-constructed questionsb:
“In the past week, how often have you kept a healthy diet?” (scored 1–5 from “never” to “always”)
“In the past week, how well do you believe you have kept a healthy diet?” (score 1˗10 from “very badly” to “very well”)
 Physical activity, hrs. per week
Short Questionnaire to Assess Health-enhancing physical activity (SQUASH) [58]
 Physical activity, days per week minimally 30 min. active
Short Questionnaire to Assess Health-enhancing physical activity (SQUASH) [58]
 Weight maintenance
Body mass index (BMI) [59], ratio of body weight (kg) and the square of height (m)
 Smoking behavior
Current smoking on daily or nondaily basis) (yes/no)
Amount of tobacco per day
aScored as T-scores (Hays norm-based scoring algorithm)[50]
bThe items were combined by a categorical principal-components analysis [60] to obtain a single z-score for dietary adherence

Statistical analyses

The PPPQ does not intend to measure a single underlying concept, thus, homogeneity of items is not assumed. Consequently, no factor analysis was performed. The internal consistency and intercorrelations of the items were explored for possible associations [30, 31].
Descriptives were calculated of patient characteristics, PPPQ, and related constructs.
Item characteristics of the PPPQ were examined by evaluating the presence of floor and ceiling effects, based on more than 15% of patients achieving the lowest or highest possible score [30].
To examine construct validity, correlations were calculated between baseline PPPQ items and similar constructs. Additionally, since the progress scores assess change in QoL or self-management behavior, they were correlated with change scores of related constructs (follow-up subtracted by baseline). Due to the small number of patients in the E-HELD study, more emphasis was placed on the magnitude of the association than on statistical significance.
For the CKD sample, the QoL-item on dependency was not relevant and therefore not included. For the dialysis sample, self-management was not assessed, as it was not part of the intervention.

Results

Questionnaire development

Feasibility PPPQ

None of the interviewed patients reported difficulties with comprehending or answering the questionnaire: questions were considered clear and easy to understand. The QoL and self-management areas of were considered relevant for patients with a kidney disease. Additionally, patients had no trouble selecting areas as personal priorities. Patients completed the questionnaire in 2–4 min.

Questionnaire evaluation

Patient characteristics

For the E-GOAL study, 460 patients with CKD not on dialysis completed screening questionnaires of whom 146 were eligible for randomization. Of these patients, 121 were included in the trial.
For the E-HELD study, 59 patients with kidney failure treated with dialysis completed screening questionnaires of whom 46 were eligible for randomization. Thirty-five were included in the trial, of whom 22 completed assessments needed for the current study’s analyses. Patient characteristics are shown in Table 2.
Table 2
Patient characteristics
 
CKD patients (N = 121)
Dialysis patients (N = 22)
Age, mean (SD)
55.95 (13.87)
65.50 (11.68)
 Median
57.31
67.00
 Range
25.77–81.59
46.00–83.00
Male sex
56.7%
54.5%
Education level
  
 Lower
52.9%
45.5%
 Higher
46.3%
54.5%
 Unknown
0.8%
-
Marital status, with partner
73.6%
95.5%
Comorbidity
69.4%
86.4%
 Hypertension
39.7%
50.0%
 Heart disease
19.0%
40.9%
 Diabetes
16.5%
31.8%
 Gastrointestinal disease
9.1%
27.3%
 Lung disease
6.6%
18.2%
 Cancer
5.8%
9.1%
Physical quality of life (PCS, RAND SF-36)
35.97 (8.64)
34.18 (7.14)
Mental quality of life (MCS, RAND SF-36)
39.81 (8.68)
44.18 (9.22)
Lower education includes primary, pre-vocational, and vocational education; higher education includes advanced secondary and tertiary education.
CKD chronic kidney disease, SD standard deviation, PCS physical component summary, RAND SF-36 RAND Short Form-36 Health Status Inventory, MCS mental component summary
Table 3 provides the descriptives of the PPPQ and related constructs. Internal consistency of the baseline PPPQ QoL items was α = 0.74 (CKD sample) and α = 0.60 (dialysis sample) and of the progress items α = 0.88 (CKD sample) and α = 0.80 (dialysis sample). In the CKD sample, the self-management items showed an internal consistency of α = 0.42 (baseline items) and α = 0.69 (progress items). Intercorrelations between the PPPQ items can be found in Supplementary File 3.
Table 3
Descriptives of the Personalized Priority and Progress Questionnaire (PPPQ) and measures of related constructs
 
CKD patients (N = 121)
Dialysis patients (N = 22)
 
Baseline
Follow-upa
Baseline
Follow-upb
 
Mean (SD)
α
Mean (SD)
Α
Mean (SD)
α
Mean (SD)
α
PPPQ QoL itemsc
2.15 (0.63)
.74
0.42 (0.91)
.88
1.94 (0.43)
.60
0.27 (0.82)
.80
PPPQ self-management itemsc
3.56 (0.58)
.42
0.28 (0.74)
.69
Fatigue (SFQ)
18.98 (5.16)
.85
17.10 (5.94)
.89
20.59 (5.47)
.87
19.54 (5.75)
.86
Sleeping problems (Sleep Problem Index II, MOS Sleep scale)
40.63 (15.89)
.81
36.16 (15.90)
.81
Energy (Energy scale, RAND SF-36)
42.29 (6.41)
.63
44.31 (7.70)
.76
44.77 (8.92)
.82
41.91 (7.19)
.67
Pain (subscale RAND SF-36)
44.26 (9.60)
.73
46.33 (9.82)
.74
47.64 (11.17)
.76
47.23 (10.16)
.66
Itch (ISDL)
7.05 (2.89)
.88
6.87 (2.44)
.80
Anxiety (GAD-7)
5.49 (3.78)
.81
3.95 (3.16)
.81
2.36 (1.92)
.68
2.55 (2.44)
.72
Worrying (PSWQ)
44.79 (10.94)
.91
42.01 (11.33)
.91
Depression (PHQ-9)
7.91 (3.33)
.54
5.76 (3.78)
.74
5.73 (3.67)
.77
7.14 (4.39)
.79
Social functioning (subscale RAND SF-36)
39.07 (9.67)
.68
42.24 (10.50)
.79
39.68 (9.78)
.56
35.68 (10.47)
.78
Perceived emotional support (ISR)
14.47 (3.52)
.82
14.89 (3.47)
.82
15.68 (3.71)
.81
15.82 (3.58)
.88
Actual emotional support (ISR)
7.25 (2.00)
.77
7.22 (1.84)
.72
6.36 (2.24)
.81
6.05 (2.01)
.80
Mutual visiting (ISR)
5.35 (1.42)
.74
5.35 (1.26)
.64
5.18 (1.53)
.84
4.81 (1.62)
.53
Role limitations due to physical problems (subscale RAND SF-36)
36.18 (11.44)
.82
40.77 (11.80)
.81
30.73 (9.40)
.88
33.05 (10.40)
.84
Self-management (PiH)
80.04 (9.63)
.78
82.74 (9.27)
.81
Medication adherence (SMAQ)
5.16 (1.05)
n/a
5.25 (0.95)
n/a
Dietary adherence
0.00 (0.93)
n/a
0.35 (0.76)
n/a
Physical activity, hrs. per week (SQUASH)
17.10 (16.04)
n/a
15.54 (15.52)
n/a
BMI
27.38 (5.33)
n/a
27.16 (5.35)
n/a
Smoking, %
9.1
n/a
8.3
n/a
Amount of tobacco per day, units
0.80 (3.31)
n/a
0.50 (2.75)
n/a
Mean and standard deviations shown as mean (SD); internal consistency: Cronbach’s α; Follow-upa: 3 months follow-up; Follow-upb: 6 months follow-up; PPPQ QoL/self-management itemsc: average sum scores, items differ per assessment point, i.e. the baseline measurement assessed baseline items and the follow-up measurement assessed progress items
CKD chronic kidney disease, SD standard deviation; QoL quality of life, SFQ Shortened Fatigue Questionnaire (SFQ), MOS Sleep Scale Medical Outcomes Study Sleep Scale, RAND SF-36 RAND Short Form-36 Health Status Inventory, ISDL Impact of Chronic Skin Disease on Daily Life, GAD-7 Generalized Anxiety Disorder 7-item Scale, PSWQ Penn State Worry Questionnaire, PHQ-9 Patient Health Questionnaire depression scale, ISR Inventory for Social Reliance, PiH Partners in Health Scale, SMAQ Simplified Medication Adherence Questionnaire, SQUASH Short Questionnaire to Assess Health-enhancing physical activity, BMI body mass index

Item characteristics PPPQ

QoL

Item characteristics of the QoL items are shown in Table 4. At baseline, mean item scores ranged from 1.61 (itch) to 3.15 (fatigue) in the CKD sample and from 1.55 (anxiety and depression) to 2.86 (fatigue) in the dialysis sample. Most items covered most of the 1–5 range, except for pain and depression (1–3), and anxiety (1–2) in the dialysis sample. Floor effects were found for all items except fatigue. No ceiling effects were detected.
Table 4
Characteristics of the Personalized Priority and Progress Questionnaire (PPPQ) items
 
Baseline
Follow-up
 
CKD patients (N = 121)
Dialysis patients (N = 22)
CKD patients (N = 121)
Dialysis patients (N = 22)
Item
Mean (SD)
Floor (%)
Ceiling (%)
Range
Mean (SD)
Floor (%)
Ceiling (%)
Range
Mean (SD)
Floor (%)
Ceiling (%)
Range
Mean (SD)
Floor (%)
Ceiling (%)
Range
QoL items
                
 Fatigue
3.15 (1.12)
5.0
13.2
1–5
2.86 (1.04)
4.5
9.1
1–5
0.21 (1.14)
0.8
2.5
− 3 to 3
− 0.45 (1.18)
4.5
0
− 3 to 2
 Pain
2.08 (1.05)
36.4
0.8
1–5
1.82 (0.85)
45.5
0
1–3
0.32 (1.21)
1.7
8.3
− 3 to 3
0.27 (1.07)
0
4.5
− 2 to 3
 Itch
1.61 (0.93)
62.0
0.8
1–5
2.05 (0.72)
18.2
0
1–4
0.56 (1.25)
0
13.2
− 2 to 3
0.45 (1.10)
0
4.5
− 1 to 3
 Anxiety
2.02 (0.91)
30.6
0.8
1–5
1.55 (0.51)
45.5
0
1–2
0.57 (1.25)
0.8
8.3
− 3 to 3
0.59 (1.44)
0
18.2
− 2 to 3
 Depression
1.79 (0.87)
43.8
0
1–4
1.55 (0.60)
50.0
0
1–3
0.62 (1.29)
0.8
9.9
− 3 to 3
0.59 (1.47)
0
18.2
− 2 to 3
 Social environment
1.90 (0.96)
39.7
3.3
1–5
1.59 (0.96)
63.6
0
1–4
0.33 (1.15)
0.8
5.8
− 3 to 3
0.41 (1.30)
0
13.6
− 2 to 3
 Daily activities
2.50 (1.14)
19.8
5.8
1–5
2.27 (0.99)
18.2
0
1–4
0.32 (1.14)
1.7
5.0
− 3 to 3
0.36 (1.09)
0
4.5
− 1 to 3
 Dependency
1.86 (0.89)
40.9
0
1–4
− 0.09 (1.34)
4.5
4.5
− 3 to 3
Self-management items
                
 Medication adherence
4.45 (0.77)
0
58.7
2–5
0.23 (0.78)
0
4.1
− 2 to 3
 Healthy diet
3.39 (0.90)
1.7
8.3
1–5
0.29 (1.04)
0.8
3.3
− 3 to 3
 Physical activity
2.82 (1.04)
9.9
4.1
1–5
0.29 (1.21)
0
5.8
− 2 to 3
 Weight maintenance
2.64 (1.23)
20.7
7.4
1–5
0.17 (1.16)
0
4.1
− 2 to 3
 Non-smoking
4.52 (1.24)
9.9
85.1
1–5
0.45 (1.29)
2.5
14.9
− 3 to 3
Follow-up measures for the CKD and dialysis population took place at, respectively, 3 and 6 months follow-up.
CKD chronic kidney disease, SD standard deviation, QoL quality of life
Regarding the progress items, mean item scores ranged from 0.21 (fatigue) to 0.62 (depression) in the CKD sample and from -0.45 (fatigue) to 0.59 (anxiety and depression) in the dialysis sample. All items covered a range of at least 4 out of 7 (− 3 to 3). No floor effects were detected and only in the dialysis sample ceiling effects were detected for anxiety and depression.

Self-management

Item characteristics of the self-management items are shown in Table 4. Mean baseline item scores ranged from 2.64 (weight maintenance) to 4.52 (non-smoking) and mean progress scores from 0.17 (weight maintenance) to 0.45 (non-smoking). All items covered at least 4 out of 5 baseline scores and at least 6 out of 7 progress scores. A floor effect was found for baseline weight maintenance. Ceiling effects were found for baseline medication adherence and non-smoking. No floor and ceiling effects were detected for the progress items.

Construct validity PPPQ

QoL

Results of the baseline and progress QoL items can be found in Table 5 and 6, respectively. Across samples, most baseline items correlated at least moderately with related constructs [(−)0.31 ≤ r ≤ 0.70], except for non-meaningful or small correlations of social environment with emotional support and mutual visiting and, in the dialysis sample, of daily activities with role limitations due to physical problems and of dependency with emotional support and mutual visiting (r-values ≤ − 0.22).
Table 5
Construct validity of the baseline quality of life items of the Personalized Priority and Progress Questionnaire (PPPQ) (Pearson correlations)
  
Fatigue
Pain
Itch
Anxiety
Depression
Social environment
Daily activities
Dependency
Fatigue (SFQ)
CKD:
Dialysis:
.47**
.41
Sleeping problems (Sleep Problem Index II, MOS Sleep scale)
CKD:
Dialysis:
.42**
Energy (subscale, RAND SF-36)
CKD:
Dialysis:
− .42**
− .43*
Pain (subscale RAND SF-36)
CKD:
Dialysis:
–.68**
− .70*
Itch (ISDL)
CKD:
Dialysis:
.68**
Anxiety (GAD-7)
CKD:
Dialysis:
.67**
.32
-
Worrying (PSWQ)
CKD:
Dialysis:
.55**
-
Depression (PHQ-9)
CKD:
Dialysis:
.46**
.70**
Social functioning (subscale RAND SF-36)
CKD:
Dialysis:
− .38**
− .44**
− .35
Perceived emotional support (ISR)
CKD:
Dialysis:
-.09
-.31
.13
Actual emotional support (ISR)
CKD:
Dialysis:
-.02
− .22
.002
Mutual visiting (ISR)
CKD:
Dialysis:
− .10
− .21
− .16
Role limitations due to physical problems (subscale RAND SF-36)
CKD:
Dialysis:
− .42**
− .003
CKD chronic kidney disease, SFQ Shortened Fatigue Questionnaire (SFQ), MOS Sleep Scale Medical Outcomes Study Sleep Scale, RAND SF-36 RAND Short Form-36 Health Status Inventory, ISDL Impact of Chronic Skin Disease on Daily Life, GAD-7 Generalized Anxiety Disorder 7-item Scale, PSWQ Penn State Worry Questionnaire, PHQ-9 Patient Health Questionnaire depression scale, ISR Inventory for Social Reliance
*p < .05; **p < .01; CKD patients (N = 121); Dialysis patients (N = 22)
Table 6
Construct validity of the quality of life items of the Personalized Priority and Progress Questionnaire (PPPQ) and change scores of measurements assessing related constructs (Pearson correlations)
  
Fatigue
Pain
Itch
Anxiety
Depression
Social environment
Daily activities
Dependency
Fatigue (SFQ)
CKD:
Dialysis:
− .36**
− .39
Sleeping problems (Sleep Problem Index II, MOS Sleep scale)
CKD:
Dialysis:
− .30**
Energy (subscale, RAND SF-36)
CKD:
Dialysis:
.36**
.39
-
Pain (subscale RAND SF-36)
CKD:
Dialysis:
.14
.05
Itch (IHDL)
CKD:
Dialysis:
− .43*
-
Anxiety (GAD-7)
CKD:
Dialysis:
-
-
− .21*
− .15
Worrying (PSWQ)
CKD:
Dialysis:
-
-
− .11
Depression (PHQ-9)
CKD:
Dialysis:
-
-
− .35**
− .04
Social functioning (subscale RAND SF-36)
CKD:
Dialysis:
-
.14
.13
− .30
Perceived emotional support (ISR)
CKD:
Dialysis:
.03
− .41
− .27
Actual emotional support (ISR)
CKD:
Dialysis:
− .03
− .20
− .32
Mutual visiting (ISR)
CKD:
Dialysis:
.004
.20
− .30
Role limitations due to physical problems (subscale RAND SF-36)
CKD:
Dialysis:
.21*
− .06
CKD chronic kidney disease, SFQ Shortened Fatigue Questionnaire (SFQ), MOS Sleep Scale Medical Outcomes Study Sleep Scale, RAND SF-36 RAND Short Form-36 Health Status Inventory, ISDL Impact of Chronic Skin Disease on Daily Life, GAD-7 Generalized Anxiety Disorder 7-item Scale, PSWQ Penn State Worry Questionnaire, PHQ-9 Patient Health Questionnaire depression scale, ISR Inventory for Social Reliance
*p < .05; **p < .01; CKD patients (N = 121); Dialysis patients (N = 22)
Across samples, at least moderate correlations were found of the QoL progress scores with changes in related constructs [0.30 ≤ r ≤ (−)0.43], except for pain, anxiety, social environment, and daily activities with change in their related construct and, in the dialysis sample, for depression and dependency (r-values ≤  0.27).

Self-management

Results of the baseline and progress self-management items can be found in Tables 7 and 8, respectively. Most items showed at least moderate correlations with related constructs [0.43 ≤ r ≤ (−)0.66], except for physical activity (r = 0.23) and self-management (r-values ≤ 0.27).
Table 7
Construct validity of the baseline self-management items of the Personalized Priority and Progress Questionnaire (PPPQ) (Pearson correlation) in a CKD sample (Pearson correlation)
 
Medication adherence
Healthy diet
Physical activity
Weight maintenance
Non-smoking
Self-management (PiH)
.19*
.27**
.23*
.22*
.25**
Medication adherence (SMAQ)
.44**
Dietary adherence
.61**
Physical activity, hrs. per week (SQUASH)
.23*
-
Physical activity, days per week minimally 30 min. active
  
.43**
  
BMI
− .63**
Amount of tobacco per day
    
− .66**
CKD chronic kidney disease, PiH Partners in Health Scale, SMAQ Simplified Medication Adherence Questionnaire, SQUASH Short Questionnaire to Assess Health-enhancing physical activity, BMI body mass index
*p < .05; **p < .01, N = 121, CKD patients
Table 8
Construct validity of self-management progress items of the Personalized Priority and Progress Questionnaire (PPPQ) and change scores of measurements assessing similar constructs (Pearson correlations) in a CKD sample
 
Medication adherence
Healthy diet
Physical activity
Weight maintenance
Non-smoking
Self-management (PiH)
.09
.26**
.40**
.31**
−.02
Medication adherence (SMAQ)
.15
-
Dietary adherence
.29**
Physical activity, hrs. per week (SQUASH)
-
−.12
Physical activity, days per week minimally 30 min. active
  
.18
  
BMI
-
−.18
Amount of tobacco per day
    
−.25**
Change scores of the measurements assessing similar constructs were calculated by subtracting mean scores at baseline from mean scores at follow-up
CKD chronic kidney disease, PiH Partners in Health Scale, SMAQ Simplified Medication Adherence Questionnaire, SQUASH Short Questionnaire to Assess Health-enhancing physical activity, BMI body mass index
**p < .01, N = 121, CKD patients
The progress in physical activity (r = 0.40) and weight maintenance (r = 0.31) showed moderate correlations with change in self-management. The other items showed small correlations with their related constructs and change in self-management (r-values ≤ 0.29).

Discussion

This study aimed to develop a brief personalized instrument that (1) defines patients’ priorities for improvement, (2) measures change in QoL and self-management outcomes prioritized by individual patients, and (3) is applicable in both clinical practice and clinical trials. The resulting questionnaire, the PPPQ, includes baseline and follow-up measurements. The baseline measurement assesses personal QoL and self-management priorities for improvement. The follow-up measurement assesses the amount of self-perceived progress in QoL or self-management compared to baseline. A progress score indicates the amount of progress on the QoL or self-management area(s) prioritized by the individual patient. The PPPQ was evaluated in two kidney disease samples, showing to be a valid and feasible instrument that is easy and quick to complete.
The PPPQ showed to have good construct validity. Regarding the baseline items, moderate to large correlations were found between all items and validated questionnaires measuring related constructs. Only the scales measuring emotional support and mutual visiting did not show significant correlations with the PPPQ items social functioning and dependency. Possibly, social support was a too different construct not necessarily related to social functioning and dependency [32, 33].
Correlations between the progress items and related constructs were somewhat smaller than the correlations of the baseline items. Possibly, this is the result of different ways of determining progress. In the PPPQ, patients make their own comparison of their current versus their previous functioning, while for the related constructs change was based on the difference between two different assessments. Possibly, patients’ self-perceived change in functioning is influenced by ‘response shift’, including change in internal standards and values as part of disease adaptation [34]. No correlations were found between anxiety and depression progress and the anxiety and depression scales in the dialysis sample, which could result from almost none of the dialysis patients reporting anxiety or depression symptoms (floor effects) [30]. In the CKD patients, where at least mild symptoms of anxiety or depression were inclusion criteria, significant associations were found. To conclude, evidence was found for good construct validity of the baseline measurement, with less determined outcomes for the progress items.
Despite the PPPQ including several domains of QoL and self-management, the internal consistency of the QoL items was surprisingly good. The self-management items showed lower internal consistency, possibly because they are less related in terms of content. Weight maintenance, for example, is not necessarily related to medication adherence.
Several floor and ceiling effects were detected for the baseline items. Particularly in the dialysis sample, the small sample size probably resulted in a smaller response range. Normally, floor and ceiling effects would decrease the responsiveness of a questionnaire: they make it difficult to detect an intervention effect in participants who score on the lower scale levels before an intervention [35]. Since the PPPQ is a personalized scale that specifically addresses changes in areas patients find important, this will not be a problem. Besides, the progress score is based on the progress items that rarely showed floor or ceiling effects.

Strengths and limitations

It is increasingly recognized that a one-size-fits all approach to healthcare falls short to the complexity and diversity of individual patients. Shifting to patient-centered care (PCC) helps to better understand individual patient needs [810, 36]. For PCC to succeed, adequate tools that promote personalization are required [4]. While current instruments lack the possibility to assess an effect on outcomes that are valued by patients [14], the PPPQ identifies personally meaningful areas and uses these progress scores as an outcome measure, making it a valuable PCC tool. Another strength is the possibility to apply the PPPQ in diverse populations. The self-management items capture a range of generic lifestyle behaviors that are important for chronic disease management and prioritized by patients with chronic disease [23, 37]. The QoL items include issues that are relevant in many chronic conditions. For example, symptoms such as fatigue, sleep problems, and pain, and the impact of disease on patients’ emotional wellbeing, daily and social life are also prioritized by people with rheumatoid arthritis [38], COPD, asthma [39], spinal cord injury [40], breast cancer [41], and lung cancer [42]. Additionally, the PPPQ is flexible when it comes to removing possibly irrelevant items (e.g., itch) or adding items that are a specific problem in a particular population (e.g., dependency in dialysis patients) [2]. Depending on the relevance, it is also possible to only administer the QoL or self-management items. In this way the PPPQ can be adapted to match the specific needs of a population. Another strength is the ease and speed in which this questionnaire can be completed by patients. This is a great advantage compared to existing personalized instruments that are usually time-consuming and require trained interviewers or therapists [16].
A limitation of this study is the relatively small sample size, especially regarding the dialysis sample. Therefore, we focused more on the magnitude than on the significance of the associations. For a more robust examination of the validity of the PPPQ, larger samples of patients with diverse medical conditions are advised. Research among patients with conditions other than CKD or kidney failure is also needed to determine the applicability of the PPPQ in these populations. Another limitation is the lack of a gold standard that measures personalized health outcomes that are prioritized by patients [20]. Consequently, we had to select different questionnaires for each item to evaluate the construct validity.

Implications

The PPPQ could be of use in both clinical and research settings. Box 1 provides an overview of the applicability. In clinical settings, the PPPQ could be used as a brief tool to evaluate patients’ priorities and to keep track of patients’ functioning. By this, the PPPQ could be used to evaluate patients’ functioning in general, similar to, but shorter than, QoL questionnaires, to specifically zoom in on QoL and self-management areas that patients themselves find important. The PPPQ could be completed on a routine basis and the results discussed during patient-clinician consultations. In this way, the PPPQ results can form the starting point of a discussion on patient priorities and shared decision-making to decide on a personalized treatment plan. Patients usually find it difficult to discuss their priorities, especially if not explicitly asked by clinicians [43, 44], and clinicians may find it difficult to know what to ask each patient and lack time to discuss all potential QoL areas or self-management behaviors. The PPPQ could make it easier for patients to discuss their particular difficulties and needs. Thereby, patient-clinician communication can be facilitated [45, 46].
Box 1
Implications of the Personalized Priority and Progress Questionnaire (PPPQ) in clinical and research settings
Clinical settings
Research settings
• Identify patient priorities
• Evaluate personalized interventions by using the progress score
• Use as conversation starter for a talk on patient priorities and patient needs
• Add or remove items to match the specific needs of the study population
• Use to support shared decision-making and tailor treatment based on results
• Use both the QoL and self-management items or only the QoL or self-management items to match the specific research questions
• Monitor patients’ QoL and adherence to self-management behaviors
• All implications listed under clinical settings are applicable in intervention studies as well
QoL, quality of life
In research settings, the PPPQ is an ideal tool to evaluate the effectiveness of personalized interventions, where treatment goals vary per participant. Some participants may work on improving their coping skills regarding fatigue, while others work on improving their social relationships. When evaluating personalized treatments using general health outcomes, outcomes will be clouded by scores on areas that may be unimportant to patients and, therefore, the personalized character will be lost [3, 4, 11, 12]. Additionally, multiple questionnaires would be necessary to evaluate different treatment goals (e.g., questionnaires on fatigue and social relationships), with the consequence of decreased power, since only part of the participants worked on those particular areas [4]. Ideally, researchers would have one overall score that justifies the personalized character of the intervention. We believe the PPPQ progress score could be that score. With this score, scores on personally meaningful areas are isolated, resulting in one single score that researchers can analyze across participants. When determining this progress score, researchers can use the priorities as selected at baseline or the areas patients indicated to have actively worked on at follow-up. The latter option can be useful if there is indication of switched treatment goals over the study course. Additionally, this option can be used as check question to find out whether patients in the control condition spontaneously worked on their health. For trials with waiting-list or care-as-usual control conditions, we advise to use the baseline-selected priorities. This is in line with existing personalized measurements such as MACTAR and GAS [15, 16] that advice patients to set goals prior to randomization, which enables researchers to apply the same calculations to both control and intervention conditions [15, 16, 47].

Conclusion

To identify and monitor patient priorities over time, the PPPQ was developed. The PPPQ can be used in both clinical and research settings and proved to be a valid questionnaire that patients can easily complete without needing assistance. The PPPQ is a personalized scale that addresses changes in areas prioritized by patients themselves. A progress score can be calculated based on the areas that are personally meaningful to the individual patient. This great benefit makes the PPPQ a suitable instrument to evaluate personalized interventions in which patients work on different treatment goals. In clinical settings, the PPPQ could be used as a quick and easy tool to evaluate patients’ priorities and to monitor their functioning. With these characteristics, the PPPQ could aid in delivering high-quality care, tailored to the unique needs and priorities of every individual patient.

Acknowledgements

We would like to thank Maria Sherwood-Smith and Chiara Jongerius for their help in translating the PPPQ to English. We would also like to thank the patients for participating in the cognitive interviews, the E-GOAL study or the E-HELD study.

Declarations

Conflict of interest

The authors have no conflicts of interest to declare that are relevant to the content of this article.

Ethical approval

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Medical Ethical Committee Leiden-Delft-Den Haag, with reference numbers P17.172 (E-GOAL; Netherlands Trial Registry: NL7338) and P18.013 (E-HELD; Netherlands Trial Registry: NL7160).
Informed consent was obtained from all patients included in the study.
Patients provided informed consent regarding publishing their data.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Onze productaanbevelingen

BSL Podotherapeut Totaal

Binnen de bundel kunt u gebruik maken van boeken, tijdschriften, e-learnings, web-tv's en uitlegvideo's. BSL Podotherapeut Totaal is overal toegankelijk; via uw PC, tablet of smartphone.

Literatuur
1.
go back to reference González, A. M., Gutman, T., Lopez-Vargas, P., Anumudu, S., Arce, C. M., Craig, J. C., Dunn, L., Eckardt, K.-U., Harris, T., & Levey, A. S. (2020). Patient and caregiver priorities for outcomes in CKD: A multinational nominal group technique study. American Journal of Kidney Diseases, 76(5), 679–689.PubMedCrossRef González, A. M., Gutman, T., Lopez-Vargas, P., Anumudu, S., Arce, C. M., Craig, J. C., Dunn, L., Eckardt, K.-U., Harris, T., & Levey, A. S. (2020). Patient and caregiver priorities for outcomes in CKD: A multinational nominal group technique study. American Journal of Kidney Diseases, 76(5), 679–689.PubMedCrossRef
2.
go back to reference Tommel, J., Evers, A. W. M., van Hamersvelt, H. W., Jordens, R., van Dijk, S., Hilbrands, L. B., Hermans, M. M. H., Hollander, D. A. M. J., van de Kerkhof, J. J., ten Dam, M. A. G. J., & van Middendorp, H. (2023). “What matters to you?”: The relevance of patient priorities in dialysis care for assessment and clinical practice. Seminars in Dialysis, 36, 131–141. Tommel, J., Evers, A. W. M., van Hamersvelt, H. W., Jordens, R., van Dijk, S., Hilbrands, L. B., Hermans, M. M. H., Hollander, D. A. M. J., van de Kerkhof, J. J., ten Dam, M. A. G. J., & van Middendorp, H. (2023). “What matters to you?”: The relevance of patient priorities in dialysis care for assessment and clinical practice. Seminars in Dialysis, 36, 131–141.
3.
go back to reference Burgers, J. S., van der Weijden, T., & Bischoff, E. W. (2021). Challenges of research on person-centered care in general practice: A scoping review. Frontiers in Medicine, 8, 669491.PubMedPubMedCentralCrossRef Burgers, J. S., van der Weijden, T., & Bischoff, E. W. (2021). Challenges of research on person-centered care in general practice: A scoping review. Frontiers in Medicine, 8, 669491.PubMedPubMedCentralCrossRef
4.
go back to reference Sacristán, J. A., & Knottnerus, J. A. (2021). Individual point-of-care trials: A new approach to incorporate patient’s preferences into personalized pragmatic clinical trials. Journal of Clinical Epidemiology, 130, 152–155.PubMedCrossRef Sacristán, J. A., & Knottnerus, J. A. (2021). Individual point-of-care trials: A new approach to incorporate patient’s preferences into personalized pragmatic clinical trials. Journal of Clinical Epidemiology, 130, 152–155.PubMedCrossRef
5.
go back to reference Zeh, S., Christalle, E., Zill, J. M., Härter, M., Block, A., & Scholl, I. (2021). What do patients expect? Assessing patient-centredness from the patients’ perspective: An interview study. British Medical Journal Open, 11(7), e047810. Zeh, S., Christalle, E., Zill, J. M., Härter, M., Block, A., & Scholl, I. (2021). What do patients expect? Assessing patient-centredness from the patients’ perspective: An interview study. British Medical Journal Open, 11(7), e047810.
6.
go back to reference de Jong, Y., van der Willik, E. M., Milders, J., Meuleman, Y., Morton, R. L., Dekker, F. W., & van Diepen, M. (2021). Person centred care provision and care planning in chronic kidney disease: Which outcomes matter? A systematic review and thematic synthesis of qualitative studies. BMC Nephrology, 22(1), 1–16. de Jong, Y., van der Willik, E. M., Milders, J., Meuleman, Y., Morton, R. L., Dekker, F. W., & van Diepen, M. (2021). Person centred care provision and care planning in chronic kidney disease: Which outcomes matter? A systematic review and thematic synthesis of qualitative studies. BMC Nephrology, 22(1), 1–16.
7.
go back to reference Baker, A. (2001). Crossing the quality chasm: a new health system for the 21st century. BMJ: British Medical Journal, 323(7322), 1192.PubMedCentralCrossRef Baker, A. (2001). Crossing the quality chasm: a new health system for the 21st century. BMJ: British Medical Journal, 323(7322), 1192.PubMedCentralCrossRef
8.
go back to reference McMillan, S. S., Kendall, E., Sav, A., King, M. A., Whitty, J. A., Kelly, F., & Wheeler, A. J. (2013). Patient-centered approaches to health care: A systematic review of randomized controlled trials. Medical Care Research and Review, 70(6), 567–596.PubMedCrossRef McMillan, S. S., Kendall, E., Sav, A., King, M. A., Whitty, J. A., Kelly, F., & Wheeler, A. J. (2013). Patient-centered approaches to health care: A systematic review of randomized controlled trials. Medical Care Research and Review, 70(6), 567–596.PubMedCrossRef
9.
go back to reference Rathert, C., Wyrwich, M. D., & Boren, S. A. (2013). Patient-centered care and outcomes: A systematic review of the literature. Medical Care Research and Review, 70(4), 351–379.PubMedCrossRef Rathert, C., Wyrwich, M. D., & Boren, S. A. (2013). Patient-centered care and outcomes: A systematic review of the literature. Medical Care Research and Review, 70(4), 351–379.PubMedCrossRef
10.
go back to reference Park, M., Lee, M., Jeong, H., Jeong, M., & Go, Y. (2018). Patient-and family-centered care interventions for improving the quality of health care: A review of systematic reviews. International Journal of Nursing Studies, 87, 69–83.PubMedCrossRef Park, M., Lee, M., Jeong, H., Jeong, M., & Go, Y. (2018). Patient-and family-centered care interventions for improving the quality of health care: A review of systematic reviews. International Journal of Nursing Studies, 87, 69–83.PubMedCrossRef
11.
go back to reference Sacristán, J. A. (2013). Patient-centered medicine and patient-oriented research: Improving health outcomes for individual patients. BMC Medical Informatics and Decision Making, 13(1), 1–8.CrossRef Sacristán, J. A. (2013). Patient-centered medicine and patient-oriented research: Improving health outcomes for individual patients. BMC Medical Informatics and Decision Making, 13(1), 1–8.CrossRef
12.
go back to reference Klemm, S., van Broeckhuysen-Kloth, S., van Vliet, S., Oosterhuis, L., & Geenen, R. (2018). Personalized treatment outcomes in patients with somatoform disorder: A concept mapping study. Journal of Psychosomatic Research, 109, 19–24.PubMedCrossRef Klemm, S., van Broeckhuysen-Kloth, S., van Vliet, S., Oosterhuis, L., & Geenen, R. (2018). Personalized treatment outcomes in patients with somatoform disorder: A concept mapping study. Journal of Psychosomatic Research, 109, 19–24.PubMedCrossRef
13.
go back to reference Lesko, L., Zineh, I., & Huang, S. M. (2010). What is clinical utility and why should we care? Clinical Pharmacology & Therapeutics, 88(6), 729–733.CrossRef Lesko, L., Zineh, I., & Huang, S. M. (2010). What is clinical utility and why should we care? Clinical Pharmacology & Therapeutics, 88(6), 729–733.CrossRef
14.
go back to reference Mangin, D., Stephen, G., Bismah, V., & Risdon, C. (2016). Making patient values visible in healthcare: A systematic review of tools to assess patient treatment priorities and preferences in the context of multimorbidity. British Medical Journal Open, 6(6), e010903. Mangin, D., Stephen, G., Bismah, V., & Risdon, C. (2016). Making patient values visible in healthcare: A systematic review of tools to assess patient treatment priorities and preferences in the context of multimorbidity. British Medical Journal Open, 6(6), e010903.
15.
go back to reference Tugwell, P., Bombardier, C., Buchanan, W., Goldsmith, C., Grace, E., & Hanna, B. (1987). The MACTAR Patient Preference Disability Questionnaire–an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. The Journal of Rheumatology, 14(3), 446–451.PubMed Tugwell, P., Bombardier, C., Buchanan, W., Goldsmith, C., Grace, E., & Hanna, B. (1987). The MACTAR Patient Preference Disability Questionnaire–an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. The Journal of Rheumatology, 14(3), 446–451.PubMed
16.
go back to reference Verhoeven, A. C., Boers, M., & Van Der Liden, S. (2000). Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial. The McMaster Toronto Arthritis. The Journal of Rheumatology, 27(12), 2801–2809.PubMed Verhoeven, A. C., Boers, M., & Van Der Liden, S. (2000). Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial. The McMaster Toronto Arthritis. The Journal of Rheumatology, 27(12), 2801–2809.PubMed
17.
go back to reference Zaza, C., Stolee, P., Prkachin, K., & Psych, R. (1999). The application of goal attainment scaling in chronic pain settings. Journal of Pain and Symptom Management, 17(1), 55–64.PubMedCrossRef Zaza, C., Stolee, P., Prkachin, K., & Psych, R. (1999). The application of goal attainment scaling in chronic pain settings. Journal of Pain and Symptom Management, 17(1), 55–64.PubMedCrossRef
18.
go back to reference Åsenlöf, P., Denison, E., & Lindberg, P. (2004). Behavioral goal assessment in patients with persistent musculoskeletal pain. Physiotherapy Theory and Practice, 20(4), 243–254.CrossRef Åsenlöf, P., Denison, E., & Lindberg, P. (2004). Behavioral goal assessment in patients with persistent musculoskeletal pain. Physiotherapy Theory and Practice, 20(4), 243–254.CrossRef
19.
go back to reference Melville, L. L., Baltic, T. A., Bettcher, T. W., & Nelson, D. L. (2002). Patients’ perspectives on the self-identified goals assessment. American Journal of Occupational Therapy, 56(6), 650–659.CrossRef Melville, L. L., Baltic, T. A., Bettcher, T. W., & Nelson, D. L. (2002). Patients’ perspectives on the self-identified goals assessment. American Journal of Occupational Therapy, 56(6), 650–659.CrossRef
20.
go back to reference Stevens, A., Beurskens, A., Köke, A., & van der Weijden, T. (2013). The use of patient-specific measurement instruments in the process of goal-setting: A systematic review of available instruments and their feasibility. Clinical Rehabilitation, 27(11), 1005–1019.PubMedCrossRef Stevens, A., Beurskens, A., Köke, A., & van der Weijden, T. (2013). The use of patient-specific measurement instruments in the process of goal-setting: A systematic review of available instruments and their feasibility. Clinical Rehabilitation, 27(11), 1005–1019.PubMedCrossRef
21.
go back to reference Cardol, C. K., Tommel, J., van Middendorp, H., Ciere, Y., Sont, J. K., Evers, A. W., & van Dijk, S. (2021). Detecting and Treating Psychosocial and Lifestyle-Related Difficulties in Chronic Disease: Development and Treatment Protocol of the E-GOAL eHealth Care Pathway. International Journal of Environmental Research and Public Health, 18(6), 3292.PubMedPubMedCentralCrossRef Cardol, C. K., Tommel, J., van Middendorp, H., Ciere, Y., Sont, J. K., Evers, A. W., & van Dijk, S. (2021). Detecting and Treating Psychosocial and Lifestyle-Related Difficulties in Chronic Disease: Development and Treatment Protocol of the E-GOAL eHealth Care Pathway. International Journal of Environmental Research and Public Health, 18(6), 3292.PubMedPubMedCentralCrossRef
22.
go back to reference Tommel, J., Evers, A. W., van Hamersvelt, H. W., van Dijk, S., Chavannes, N. H., Wirken, L., Hilbrands, L. B., & van Middendorp, H. (2022). E-HEalth treatment in Long-term Dialysis (E-HELD): Study protocol for a multicenter randomized controlled trial evaluating personalized Internet-based cognitive-behavioral therapy in dialysis patients. Trials, 23(1), 1–20.CrossRef Tommel, J., Evers, A. W., van Hamersvelt, H. W., van Dijk, S., Chavannes, N. H., Wirken, L., Hilbrands, L. B., & van Middendorp, H. (2022). E-HEalth treatment in Long-term Dialysis (E-HELD): Study protocol for a multicenter randomized controlled trial evaluating personalized Internet-based cognitive-behavioral therapy in dialysis patients. Trials, 23(1), 1–20.CrossRef
23.
go back to reference Kidney disease: improving global outcomes (KDIGO) CKD work group. (2013). KDIGO 2012 clinical practice guideline for acute kidney injury. Kidney Internationaal Supplements, 3(1), 1–50. Kidney disease: improving global outcomes (KDIGO) CKD work group. (2013). KDIGO 2012 clinical practice guideline for acute kidney injury. Kidney Internationaal Supplements, 3(1), 1–50.
24.
go back to reference Abdel-Kader, K., Unruh, M. L., & Weisbord, S. D. (2009). Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clinical Journal of the American Society of Nephrology, 4(6), 1057–1064.PubMedPubMedCentralCrossRef Abdel-Kader, K., Unruh, M. L., & Weisbord, S. D. (2009). Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clinical Journal of the American Society of Nephrology, 4(6), 1057–1064.PubMedPubMedCentralCrossRef
25.
go back to reference Caplin, B., Kumar, S., & Davenport, A. (2011). Patients’ perspective of haemodialysis-associated symptoms. Nephrology Dialysis Transplantation, 26(8), 2656–2663.CrossRef Caplin, B., Kumar, S., & Davenport, A. (2011). Patients’ perspective of haemodialysis-associated symptoms. Nephrology Dialysis Transplantation, 26(8), 2656–2663.CrossRef
26.
go back to reference Tong, A., Sainsbury, P., Carter, S. M., Hall, B., Harris, D. C., Walker, R. G., Hawley, C. M., Chadban, S., & Craig, J. C. (2008). Patients’ priorities for health research: Focus group study of patients with chronic kidney disease. Nephrology Dialysis Transplantation, 23(10), 3206–3214.CrossRef Tong, A., Sainsbury, P., Carter, S. M., Hall, B., Harris, D. C., Walker, R. G., Hawley, C. M., Chadban, S., & Craig, J. C. (2008). Patients’ priorities for health research: Focus group study of patients with chronic kidney disease. Nephrology Dialysis Transplantation, 23(10), 3206–3214.CrossRef
27.
go back to reference Weisbord, S. D., Fried, L. F., Arnold, R. M., Rotondi, A. J., Fine, M. J., Levenson, D. J., & Switzer, G. E. (2004). Development of a symptom assessment instrument for chronic hemodialysis patients: The Dialysis Symptom Index. Journal of Pain and Symptom Management, 27(3), 226–240.PubMedCrossRef Weisbord, S. D., Fried, L. F., Arnold, R. M., Rotondi, A. J., Fine, M. J., Levenson, D. J., & Switzer, G. E. (2004). Development of a symptom assessment instrument for chronic hemodialysis patients: The Dialysis Symptom Index. Journal of Pain and Symptom Management, 27(3), 226–240.PubMedCrossRef
28.
go back to reference Willis, G. B. (2004). Cognitive interviewing: A tool for improving questionnaire design. Sage Publications. Willis, G. B. (2004). Cognitive interviewing: A tool for improving questionnaire design. Sage Publications.
29.
go back to reference Maneesriwongul, W., & Dixon, J. K. (2004). Instrument translation process: A methods review. Journal of Advanced Nursing, 48(2), 175–186.PubMedCrossRef Maneesriwongul, W., & Dixon, J. K. (2004). Instrument translation process: A methods review. Journal of Advanced Nursing, 48(2), 175–186.PubMedCrossRef
30.
go back to reference Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., Bouter, L. M., & de Vet, H. C. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42.PubMedCrossRef Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., Bouter, L. M., & de Vet, H. C. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42.PubMedCrossRef
31.
go back to reference Streiner, D. L. (2003). Being inconsistent about consistency: When coefficient alpha does and doesn’t matter. Journal of Personality Assessment, 80(3), 217–222.PubMedCrossRef Streiner, D. L. (2003). Being inconsistent about consistency: When coefficient alpha does and doesn’t matter. Journal of Personality Assessment, 80(3), 217–222.PubMedCrossRef
32.
go back to reference Crowe, L. M., Beauchamp, M. H., Catroppa, C., & Anderson, V. (2011). Social function assessment tools for children and adolescents: A systematic review from 1988 to 2010. Clinical Psychology Review, 31(5), 767–785.PubMedCrossRef Crowe, L. M., Beauchamp, M. H., Catroppa, C., & Anderson, V. (2011). Social function assessment tools for children and adolescents: A systematic review from 1988 to 2010. Clinical Psychology Review, 31(5), 767–785.PubMedCrossRef
33.
go back to reference Taylor, S. E. (2011). Social support: A review. In H. S. Friedman (Ed.), The Oxford handbook of health psychology (pp. 189–214). Oxford University Press. Taylor, S. E. (2011). Social support: A review. In H. S. Friedman (Ed.), The Oxford handbook of health psychology (pp. 189–214). Oxford University Press.
34.
go back to reference Sprangers, M. A., & Schwartz, C. E. (1999). Integrating response shift into health-related quality of life research: A theoretical model. Social Science & Medicine, 48(11), 1507–1515.CrossRef Sprangers, M. A., & Schwartz, C. E. (1999). Integrating response shift into health-related quality of life research: A theoretical model. Social Science & Medicine, 48(11), 1507–1515.CrossRef
35.
go back to reference Bot, S., Terwee, C., Van der Windt, D., Bouter, L., Dekker, J., & De Vet, H. (2004). Clinimetric evaluation of shoulder disability questionnaires: A systematic review of the literature. Annals of the Rheumatic Diseases, 63(4), 335–341.PubMedPubMedCentralCrossRef Bot, S., Terwee, C., Van der Windt, D., Bouter, L., Dekker, J., & De Vet, H. (2004). Clinimetric evaluation of shoulder disability questionnaires: A systematic review of the literature. Annals of the Rheumatic Diseases, 63(4), 335–341.PubMedPubMedCentralCrossRef
36.
go back to reference Morgan, S., & Yoder, L. H. (2012). A concept analysis of person-centered care. Journal of Holistic Nursing, 30(1), 6–15.PubMedCrossRef Morgan, S., & Yoder, L. H. (2012). A concept analysis of person-centered care. Journal of Holistic Nursing, 30(1), 6–15.PubMedCrossRef
37.
go back to reference Hessler, D. M., Fisher, L., Bowyer, V., Dickinson, L. M., Jortberg, B. T., Kwan, B., Fernald, D. H., Simpson, M., & Dickinson, W. P. (2019). Self-management support for chronic disease in primary care: Frequency of patient self-management problems and patient reported priorities, and alignment with ultimate behavior goal selection. BMC Family Practice, 20(1), 120.PubMedPubMedCentralCrossRef Hessler, D. M., Fisher, L., Bowyer, V., Dickinson, L. M., Jortberg, B. T., Kwan, B., Fernald, D. H., Simpson, M., & Dickinson, W. P. (2019). Self-management support for chronic disease in primary care: Frequency of patient self-management problems and patient reported priorities, and alignment with ultimate behavior goal selection. BMC Family Practice, 20(1), 120.PubMedPubMedCentralCrossRef
38.
go back to reference Heiberg, T., Finset, A., Uhlig, T., & Kvien, T. (2005). Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 64(2), 191–195.PubMedPubMedCentralCrossRef Heiberg, T., Finset, A., Uhlig, T., & Kvien, T. (2005). Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 64(2), 191–195.PubMedPubMedCentralCrossRef
39.
go back to reference Francisca Caron-Flinterman, J., Broerse, J. E. W., Teerling, J., & Bunders, J. F. G. (2005). Patients’ priorities concerning health research: The case of asthma and COPD research in the Netherlands. Health Expectations, 8(3), 253–263.PubMedPubMedCentralCrossRef Francisca Caron-Flinterman, J., Broerse, J. E. W., Teerling, J., & Bunders, J. F. G. (2005). Patients’ priorities concerning health research: The case of asthma and COPD research in the Netherlands. Health Expectations, 8(3), 253–263.PubMedPubMedCentralCrossRef
40.
go back to reference Hammell, K. R. W. (2010). Spinal cord injury rehabilitation research: Patient priorities, current deficiencies and potential directions. Disability and Rehabilitation, 32(14), 1209–1218.PubMedCrossRef Hammell, K. R. W. (2010). Spinal cord injury rehabilitation research: Patient priorities, current deficiencies and potential directions. Disability and Rehabilitation, 32(14), 1209–1218.PubMedCrossRef
41.
go back to reference Tometich, D. B., Mosher, C. E., Hirsh, A. T., Rand, K. L., Johns, S. A., Matthias, M. S., Outcalt, S. D., Schneider, B. P., Mina, L., Storniolo, A. M. V., Newton, E. V., & Miller, K. D. (2018). Metastatic breast cancer patients’ expectations and priorities for symptom improvement. Supportive Care in Cancer, 26(11), 3781–3788.PubMedPubMedCentralCrossRef Tometich, D. B., Mosher, C. E., Hirsh, A. T., Rand, K. L., Johns, S. A., Matthias, M. S., Outcalt, S. D., Schneider, B. P., Mina, L., Storniolo, A. M. V., Newton, E. V., & Miller, K. D. (2018). Metastatic breast cancer patients’ expectations and priorities for symptom improvement. Supportive Care in Cancer, 26(11), 3781–3788.PubMedPubMedCentralCrossRef
42.
go back to reference Krueger, E., Secinti, E., Wu, W., Hanna, N., Durm, G., Einhorn, L., Jalal, S., & Mosher, C. E. (2021). Measurement of patients’ acceptable symptom levels and priorities for symptom improvement in advanced lung cancer. Supportive Care in Cancer, 29(10), 5895–5904.PubMedPubMedCentralCrossRef Krueger, E., Secinti, E., Wu, W., Hanna, N., Durm, G., Einhorn, L., Jalal, S., & Mosher, C. E. (2021). Measurement of patients’ acceptable symptom levels and priorities for symptom improvement in advanced lung cancer. Supportive Care in Cancer, 29(10), 5895–5904.PubMedPubMedCentralCrossRef
43.
go back to reference Pugh-Clarke, K., Read, S. C., & Sim, J. (2017). Symptom experience in non-dialysis-dependent chronic kidney disease: A qualitative descriptive study. Journal of Renal Care, 43(4), 197–208.PubMedCrossRef Pugh-Clarke, K., Read, S. C., & Sim, J. (2017). Symptom experience in non-dialysis-dependent chronic kidney disease: A qualitative descriptive study. Journal of Renal Care, 43(4), 197–208.PubMedCrossRef
44.
go back to reference Feldman, R., Berman, N., Reid, M. C., Roberts, J., Shengelia, R., Christianer, K., Eiss, B., & Adelman, R. D. (2013). Improving symptom management in hemodialysis patients: Identifying barriers and future directions. Journal of Palliative Medicine, 16(12), 1528–1533.PubMedPubMedCentralCrossRef Feldman, R., Berman, N., Reid, M. C., Roberts, J., Shengelia, R., Christianer, K., Eiss, B., & Adelman, R. D. (2013). Improving symptom management in hemodialysis patients: Identifying barriers and future directions. Journal of Palliative Medicine, 16(12), 1528–1533.PubMedPubMedCentralCrossRef
45.
go back to reference Anderson, N. E., Calvert, M., Cockwell, P., Dutton, M., & Kyte, D. (2019). The use of patient-reported outcomes in patients treated with maintenance hemodialysis: A perspective. American Journal of Kidney Diseases, 74(3), 399–406.PubMedCrossRef Anderson, N. E., Calvert, M., Cockwell, P., Dutton, M., & Kyte, D. (2019). The use of patient-reported outcomes in patients treated with maintenance hemodialysis: A perspective. American Journal of Kidney Diseases, 74(3), 399–406.PubMedCrossRef
46.
go back to reference van der Willik, E. M., Hemmelder, M. H., Bart, H. A., van Ittersum, F. J., Hoogendijk-van den Akker, J. M., Bos, W. J. W., Dekker, F. W., & Meuleman, Y. (2020). Routinely measuring symptom burden and health-related quality of life in dialysis patients: First results from the Dutch registry of patient-reported outcome measures. Clinical Kidney Journal, 14(6), 1535–1544.PubMedPubMedCentralCrossRef van der Willik, E. M., Hemmelder, M. H., Bart, H. A., van Ittersum, F. J., Hoogendijk-van den Akker, J. M., Bos, W. J. W., Dekker, F. W., & Meuleman, Y. (2020). Routinely measuring symptom burden and health-related quality of life in dialysis patients: First results from the Dutch registry of patient-reported outcome measures. Clinical Kidney Journal, 14(6), 1535–1544.PubMedPubMedCentralCrossRef
47.
go back to reference Ruble, L., McGrew, J. H., & Toland, M. D. (2012). Goal attainment scaling as an outcome measure in randomized controlled trials of psychosocial interventions in autism. Journal of Autism and Developmental Disorders, 42(9), 1974–1983.PubMedPubMedCentralCrossRef Ruble, L., McGrew, J. H., & Toland, M. D. (2012). Goal attainment scaling as an outcome measure in randomized controlled trials of psychosocial interventions in autism. Journal of Autism and Developmental Disorders, 42(9), 1974–1983.PubMedPubMedCentralCrossRef
48.
go back to reference Vercoulen, J. H., Swanink, C. M., Fennis, J. F., Galama, J. M., van der Meer, J. W., & Bleijenberg, G. (1994). Dimensional assessment of chronic fatigue syndrome. Journal of Psychosomatic Research, 38(5), 383–392.PubMedCrossRef Vercoulen, J. H., Swanink, C. M., Fennis, J. F., Galama, J. M., van der Meer, J. W., & Bleijenberg, G. (1994). Dimensional assessment of chronic fatigue syndrome. Journal of Psychosomatic Research, 38(5), 383–392.PubMedCrossRef
49.
go back to reference Stewart, A. L., Ware, J. E., & Ware, J. E., Jr. (1992). Measuring functioning and well-being: the medical outcomes study approach. Duke University Press. Stewart, A. L., Ware, J. E., & Ware, J. E., Jr. (1992). Measuring functioning and well-being: the medical outcomes study approach. Duke University Press.
50.
go back to reference Hays, R. D., Sherbourne, C. D., & Mazel, R. M. (1993). The rand 36-item health survey 1.0. Health Economics, 2(3), 217–227.PubMedCrossRef Hays, R. D., Sherbourne, C. D., & Mazel, R. M. (1993). The rand 36-item health survey 1.0. Health Economics, 2(3), 217–227.PubMedCrossRef
51.
go back to reference Evers, A., Duller, P., Van De Kerkhof, P., Van der Valk, P., De Jong, E., Gerritsen, M., Otero, E., Verhoeven, E., Verhaak, C., & Kraaimaat, F. (2008). The Impact of Chronic Skin Disease on Daily Life (ISDL): A generic and dermatology-specific health instrument. British Journal of Dermatology, 158(1), 101–108.PubMed Evers, A., Duller, P., Van De Kerkhof, P., Van der Valk, P., De Jong, E., Gerritsen, M., Otero, E., Verhoeven, E., Verhaak, C., & Kraaimaat, F. (2008). The Impact of Chronic Skin Disease on Daily Life (ISDL): A generic and dermatology-specific health instrument. British Journal of Dermatology, 158(1), 101–108.PubMed
52.
go back to reference Spitzer, R. L., Kroenke, K., Williams, J. B., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097.PubMedCrossRef Spitzer, R. L., Kroenke, K., Williams, J. B., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097.PubMedCrossRef
53.
go back to reference Meyer, T. J., Miller, M. L., Metzger, R. L., & Borkovec, T. D. (1990). Development and validation of the Penn State Worry Questionnaire. Behaviour Research and Therapy, 28(6), 487–495.PubMedCrossRef Meyer, T. J., Miller, M. L., Metzger, R. L., & Borkovec, T. D. (1990). Development and validation of the Penn State Worry Questionnaire. Behaviour Research and Therapy, 28(6), 487–495.PubMedCrossRef
54.
go back to reference Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613.PubMedPubMedCentralCrossRef Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613.PubMedPubMedCentralCrossRef
55.
go back to reference Dam-Baggen, V., & Kraaimaat, F. (1992). De Inventarisatielijst Sociale Betrokkenheid (ISB): Een zelfbeoordelingslijst om sociale steun te meten. [The Inventory for Social Support (ISB): A self-report inventory for the measurement of social support]. Gedragstherapie, 25, 27–46. Dam-Baggen, V., & Kraaimaat, F. (1992). De Inventarisatielijst Sociale Betrokkenheid (ISB): Een zelfbeoordelingslijst om sociale steun te meten. [The Inventory for Social Support (ISB): A self-report inventory for the measurement of social support]. Gedragstherapie, 25, 27–46.
56.
go back to reference Petkov, J., Harvey, P., & Battersby, M. (2010). The internal consistency and construct validity of the partners in health scale: Validation of a patient rated chronic condition self-management measure. Quality of Life Research, 19(7), 1079–1085.PubMedCrossRef Petkov, J., Harvey, P., & Battersby, M. (2010). The internal consistency and construct validity of the partners in health scale: Validation of a patient rated chronic condition self-management measure. Quality of Life Research, 19(7), 1079–1085.PubMedCrossRef
57.
go back to reference Knobel, H., Alonso, J., Casado, J. L., Collazos, J., González, J., Ruiz, I., Kindelan, J. M., Carmona, A., Juega, J., & Ocampo, A. (2002). Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: The GEEMA Study. AIDS, 16(4), 605–613.PubMedCrossRef Knobel, H., Alonso, J., Casado, J. L., Collazos, J., González, J., Ruiz, I., Kindelan, J. M., Carmona, A., Juega, J., & Ocampo, A. (2002). Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: The GEEMA Study. AIDS, 16(4), 605–613.PubMedCrossRef
58.
go back to reference Wendel-Vos, G. C., Schuit, A. J., Saris, W. H., & Kromhout, D. (2003). Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. Journal of Clinical Epidemiology, 56(12), 1163–1169.PubMedCrossRef Wendel-Vos, G. C., Schuit, A. J., Saris, W. H., & Kromhout, D. (2003). Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. Journal of Clinical Epidemiology, 56(12), 1163–1169.PubMedCrossRef
59.
go back to reference World Health Organization. (2000). Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization Technical Report Series, 894, 1–253. World Health Organization. (2000). Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization Technical Report Series, 894, 1–253.
60.
go back to reference Linting, M., & van der Kooij, A. (2012). Nonlinear principal components analysis with CATPCA: A tutorial. Journal of Personality Assessment, 94(1), 12–25.PubMedCrossRef Linting, M., & van der Kooij, A. (2012). Nonlinear principal components analysis with CATPCA: A tutorial. Journal of Personality Assessment, 94(1), 12–25.PubMedCrossRef
Metagegevens
Titel
The Personalized Priority and Progress Questionnaire (PPPQ): A personalized instrument for quality of life and self-management for use in clinical trials and practice
Auteurs
Judith Tommel
Cinderella K. Cardol
Andrea W. M. Evers
Rianne Stuivenberg
Sandra van Dijk
Henriët van Middendorp
Publicatiedatum
12-05-2023
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 10/2023
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-023-03429-7

Andere artikelen Uitgave 10/2023

Quality of Life Research 10/2023 Naar de uitgave